Rebecca S.

Rebecca S. is an accomplished Area Sales Manager at Geneo, responsible for the capital launch of the Geneo X ~GLO2 Facial device, which became the fastest-growing facial aesthetics device in 2023 with expectations to lead the market in 2024. With extensive experience in sales and business development in the medical aesthetic sector, Rebecca has held various positions including Regional Key Account Manager at Cutera, Inc., and Founder/CEO of MedAesthetic Solutions, LLC, where capabilities included consultative sales and training across multiple medical disciplines. Rebecca has also served as Aesthetics Director of Sales & Education for The Woman's Group, Senior Aesthetics Territory Manager for Revision Skincare®, and Business Development Manager for iS CLINICAL, showcasing a strong track record in strategic planning, staff training, and marketing execution in both products and services. Educational background includes a Bachelor of Arts in Business/Marketing Communications from Louisiana State University.